This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The five strategies were: immediate empirical antibiotics; delayed (by 48 hours) empirical antibiotics; targeted antibiotics based on a high symptom score, of two or more, from urine cloudiness, smell, nocturia, and dysuria; targeted antibiotics based on dipstick results, for nitrite or leucocytes and traces of blood; targeted antibiotics based on a midstream urine analysis, with symptomatic treatment until the culture and sensitivity results were available.
Location/setting
UK/primary care.
Methods

Analytical approach:
The authors conducted an economic evaluation based on a single trial, with one month of follow-up. The authors stated that the perspective was that of the UK National Health Service (NHS).
Effectiveness data:
The effectiveness of each of the interventions was based on a randomised controlled trial (RCT) of 309 women, aged 18 to 70 years, who were not pregnant and who had a suspected urinary tract infection, either for the first time or as a recurrence (Little, et al. 2010 , see 'Other Publications of Related Interest' below for bibliographic details). These women completed a symptom diary for 14 days and they were randomised to one of the five interventions.
Monetary benefit and utility valuations:
: In a secondary analysis, a utility decrement was applied to the days when patients experienced urinary tract infection symptoms, using data from a published study (Barry, et al. 1997 , see 'Other Publications of Related Interest' below for bibliographic details).
Measure of benefit:
The primary measure of benefit was the number of days without moderate or severe symptoms. A secondary measure of benefit was quality-adjusted life-years (QALYs) gained.
